With the increasing application of biologics agents, the psoriasiform reaction during dupilumab therapy has been reported in AD, and an eczematous reaction to anti-interleukin (IL)-17 treatment has been reported in psoriasis (65, 66). The gene discussed is IL17A; the disease is Alzheimer disease.